Sign in to view content

Potential Safety Concerns of Bevacizumab for Retinopathy of Prematurity

Robert L. Avery, MD

Video
Published 2016

Related

Economic Impact of the Use of Anti-VEGF Monotherapy or in Combination With Panretinal Photocoagulation
Swati Agarwal-Sinha, MD, FASRS
Annual Meeting Talks
Patients Ultra-Responsive to Ranibizumab (RBZ): Rates of Great Than or Equal to 4-Step Improvement in Diabetic Retinopathy Severity in DRCR.net Protocol S
Allen Chiang, MD, FASRS
Annual Meeting Talks
2019
Episode 17: 5-year Results of DRCR.net Protocol S: PRP laser vs Ranibizumab for PDR with Dr. Jennifer Sun
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018

Category: Pediatric Retina

See more